Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections

This cohort study examines the use of intravitreal injections of vascular endothelial growth factor inhibitor in Denmark from 2007 through 2022 and forecasts future demand for this therapy.

Detalles Bibliográficos
Autores principales: Thinggaard, Benjamin Sommer, Pedersen, Frederik, Grauslund, Jakob, Stokholm, Lonny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517372/
https://www.ncbi.nlm.nih.gov/pubmed/37738053
http://dx.doi.org/10.1001/jamanetworkopen.2023.35148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517372/
https://www.ncbi.nlm.nih.gov/pubmed/37738053
http://dx.doi.org/10.1001/jamanetworkopen.2023.35148

Ejemplares similares